Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Successful Long-term Use of Oral Isotretinoin for the Management of Morbihan Disease: A Case Series Report and Review of the Literature.

Smith LA, Cohen DE.

Arch Dermatol. 2012 Dec;148(12):1395-8. doi: 10.1001/archdermatol.2012.3109.

PMID:
23403940
2.

[Morbihan disease as a special form of rosacea: review of pathogenesis and new therapeutic options].

Balakirski G, Baron JM, Megahed M.

Hautarzt. 2013 Dec;64(12):884-6. doi: 10.1007/s00105-013-2642-x. Review. German.

PMID:
24201653
3.

Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin.

Scheinfeld N, Bangalore S.

J Drugs Dermatol. 2006 May;5(5):467-8. Review.

PMID:
16703787
4.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
5.

The management of rosacea.

Rebora A.

Am J Clin Dermatol. 2002;3(7):489-96. Review.

PMID:
12180896
6.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
7.

Updates on the pathophysiology and management of acne rosacea.

Elsaie ML, Choudhary S.

Postgrad Med. 2009 Sep;121(5):178-86. doi: 10.3810/pgm.2009.09.2066. Review.

PMID:
19820288
8.

The retinoids. A review of their clinical pharmacology and therapeutic use.

Orfanos CE, Ehlert R, Gollnick H.

Drugs. 1987 Oct;34(4):459-503. Review.

PMID:
3315625
9.

Oral isotretinoin treatment policy. Do we all agree?

Ortonne JP.

Dermatology. 1997;195 Suppl 1:34-7; discussion 38-40. Review.

PMID:
9310744
10.

A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.

Thornton J, Ashcroft D, O'Neill T, Elliott R, Adams J, Roberts C, Rooney M, Symmons D.

Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. Review.

11.

Etiopathogenesis, classification, and current trends in treatment of rosacea.

Tisma VS, Basta-Juzbasić A, Dobrić I, Ljubojević S, Mokos ZB.

Acta Dermatovenerol Croat. 2003 Dec;11(4):236-46. Review.

PMID:
14670225
12.

Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature.

Alijotas-Reig J, Garcia-Gimenez V.

J Eur Acad Dermatol Venereol. 2008 Feb;22(2):150-61. doi: 10.1111/j.1468-3083.2007.02354.x. Review.

PMID:
18211407
13.

Current topical and systemic approaches to treatment of rosacea.

Korting HC, Schöllmann C.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):876-82. doi: 10.1111/j.1468-3083.2009.03167.x. Review.

PMID:
19508315
14.

Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.

Ward A, Brogden RN, Heel RC, Speight TM, Avery GS.

Drugs. 1984 Jul;28(1):6-37. Review.

PMID:
6235105

Supplemental Content

Support Center